Key Market Indicators
Ivorian malaria prevalence is projected to hit 6.7 million cases by 2026, up from 5.4 million in 2021. This marks an average annual growth rate of 3.5%. Since 2005, Ivorian demand has grown 8% on average each year. In 2021, Angola overtook the Ivory Coast to become the 12th-highest country in terms of malaria cases, with 5.4 million. Nigeria, Burkina Faso and Mozambique came in second, third and fourth place, respectively.
Ivory Coast Malaria Market Data and Forecasts
How much will Ivory Coast Malaria Market grow to 2026?
More in Malaria Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
Malaria Testing Market: Exploring Sales Forecasts, Competitive Strategies, and Emerging Technologies
The domain of malaria diagnostics has witnessed fascinating advancements, thanks to biotechnological evolutions. The advent of numerous novel, arguably game-changing detection methods promises a significant shift from conventional techniques to quick, accurate, and efficient systems. These emergent technologies display immense potential to revolutionize the market, drive exponential growth, and fast-track...
Discover more insights -
Malaria Diagnostic Markets: Unveiling Evolving Opportunities and Progressive Strategies
The malaria diagnostic market observes a shift towards advanced, accurate, and fast diagnostic tools. Increasing instances of malaria epidemics globally emphasize the adoption of innovative diagnostic solutions. Rapid Diagnostic Tests (RDTs), molecular diagnostics, and mobile-based applications are increasingly being utilized, spurred by technological advancements.
Discover more insights -
Decoding Global Trends in Malaria Treatment: A Comprehensive Market Overview
Globally, there is an sustained emphasis on the prevention and eradication of malaria, which is evident by the continual investment in research and development by international health bodies as well as corporate entities. Although there is a persistent focus on vaccine development, the demand for effective treatments remains high due...
Discover more insights